Skip to main content
MJHS
Navigation
Journal Navigation
Article Navigation
Development of a mathematical model for thrombosis risk prediction using serum biomarkers
Dan Croitoru1, Iurie Trohin1, Ecaterina Pavlovschi2, Oleg Arnaut3, Eugen Cerevan4
https://doi.org/10.52645/MJHS.2025.2.03
Thrombosis is a frequently underdiagnosed condition associated with high mortality in neglected cases. Many factors, including geoheliophysical and biochemical ones, are responsible for thrombosis modulation. Routine investigations may sometimes be inconsistent and, thus, unreliable in a clinical setting.
Thrombosis and hemostatic abnormalities in non-Hodgkin lymphoma
Sanda Buruiana1*, Minodora Mazur2
https://doi.org/10.52645/MJHS.2025.2.02
Non-Hodgkin lymphoma is a heterogeneous group of malignant lymphoid tumors. Hemostasis disorders in non-Hodgkin lymphoma are often asymptomatic but can develop into severe complications. The risk of venous thromboembolism increases according to the totality of risk factors assessed directly in each individual patient, based on age, gender, comorbidities, performance status, and both congenital and acquired thrombophilia